Cargando…
ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
ETS transcription factor ELK3 (ELK3), a novel oncogene, affects pathological processes and progression of many cancers in human tissues. However, it remains unclear whether ELK3, as a key gene, affects the pathological process of gliomas and the prognosis of patients with gliomas. This study aimed t...
Autores principales: | Liu, Zhendong, Ren, Zhishuai, Zhang, Cheng, Qian, Rongjun, Wang, Hongbo, Wang, Jialin, Zhang, Wang, Liu, Binfeng, Lian, Xiaoyu, Wang, Yanbiao, Guo, Yuqi, Gao, Yanzheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716454/ https://www.ncbi.nlm.nih.gov/pubmed/34976781 http://dx.doi.org/10.3389/fonc.2021.608748 |
Ejemplares similares
-
Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021) -
Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021) -
GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022) -
Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma
por: Cheng, Xingbo, et al.
Publicado: (2022) -
Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021)